From 2010 to 2013 in Japan, we isolated 11 swine influenza viruses (SIVs) from pigs showing respiratory symptoms. Sequence and phylogenetic analyses showed that 6 H1N1 viruses originated from the pandemic (H1N1) 2009 (pdm 09) virus and the other 5 viruses were reassortants between SIVs and pdm 09 viruses, representing 4 genotypes. Two H1N2 viruses contained H1 and N2 genes originated from Japanese H1N2 SIV together with internal genes of pdm 09 viruses. Additionally, 1 H1N2 virus contained a further NP gene originating from Japanese H1N2 SIV. One H1N1 virus contained only the H1 gene originating from Japanese H1 SIV in a pdm 09 virus background. One H3N2 virus contained H3 and N2 genes originating from Japanese H3N2 SIV together with internal genes of pdm 09 virus. The results indicate that pdm 09 viruses are distributed widely in the Japanese swine population and that several reassortments with Japanese SIVs have occurred.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272978 | PMC |
| http://dx.doi.org/10.1292/jvms.14-0194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Two genotypes of H3N2 swine influenza viruses identified in pigs from Shandong Province, China.
Front Cell Infect Microbiol
January 2025
College of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai'an, China.
Swine influenza virus (SIV) is a highly contagious pathogen that poses significant economic challenges to the swine industry and carries zoonotic potential, underscoring the need for vigilant surveillance. In this study, we performed a comprehensive genetic and molecular analysis of H3N2 SIV isolates obtained from 372 swine samples collected in Shandong Province, China. Phylogenetic analysis revealed two distinct genotypes.
View Article and Find Full Text PDFInfluenza A(H5N1) shedding in air corresponds to transmissibility in mammals.
Nat Microbiol
January 2025
Department of Viroscience, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Article Synopsis
- An increase in spillover events of avian influenza A(H5N1) to mammals indicates that certain virus strains are adapting for better transmission among mammals.
- Research using air-sampling devices to monitor ferrets shows that earlier strains of A(H5N1) didn't effectively transmit due to low airborne virus shedding, not a lack of mutations needed for adaptation.
- In contrast, while human A(H1N1) was easily detected in the air, some A(H5N1) strains from 2005 and 2024 were not, although a couple of ferrets infected with a 2022 European polecat strain and a 2024 strain from a farm worker did shed infectious virus.
Article Synopsis
- The study assesses rising seasonal influenza rates in China since 2018, focusing on four types of viruses and analyzing data related to gender, age, and season using a logistic regression model.
- Significant trends in infection rates were observed: an increase from 2018 to 2019 and 2021 to 2022, but a decrease between 2019 and 2021.
- The highest rates of infection were found in adolescents aged 18-30, and the impact of different virus types was ranked, with Influenza B/Victoria being the most significant.
An effective vaccine against influenza A virus based on the matrix protein 2 (M2).
Vet Microbiol
November 2024
Department of Biochemistry, 505 South Goodwin Avenue, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
The ever-increasing antigenic diversity of the hemagglutinin (HA) of influenza A virus (IAV) poses a significant challenge for effective vaccine development. Notably, the matrix protein 2 (M2) is a highly conserved 97 amino acid long transmembrane tetrameric protein present in the envelope of IAV. More than 99 % of IAV strains circulating in American swine herds share the identical pandemic (pdm) isoform of M2, making it an ideal target antigen for a vaccine that could elicit broadly protective immunity.
View Article and Find Full Text PDFLinQURE: A novel AAV gene silencing platform that supports multi-transcript targeting for complex disorders.
Mol Ther Nucleic Acids
September 2024
Global Research, uniQure biopharma B.V., 1105 BP Amsterdam, the Netherlands.
Article Synopsis
- - Recombinant adeno-associated virus (rAAV) gene therapies have great potential for treating various genetic disorders, requiring ongoing innovation in their development.
- - The novel miQURE technology utilizes microRNAs to target and silence toxic genes, and has evolved into the linQURE platform, which allows for simultaneous control of multiple gene expressions.
- - By demonstrating the capability to express two synthetic miRNAs together, linQURE enhances the effectiveness of gene therapy for complex diseases with multiple genetic contributors, ultimately broadening treatment options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!